The primary endpoint of this study is number of unplanned/ unanticipated surgical breast procedures. Other endpoints in the trial will be secondary. 24 months [clinicaltrials_resource:088cfec033000d0d544b2cedf58ae203]
Follow-up time after primary surgery is 24 months.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
The primary endpoint of this study is number of unplanned/ unanticipated surgical breast procedures. Other endpoints in the trial will be secondary. 24 months [clinicaltrials_resource:088cfec033000d0d544b2cedf58ae203]
Follow-up time after primary surgery is 24 months.
Bio2RDF identifier
088cfec033000d0d544b2cedf58ae203
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:088cfec033000d0d544b2cedf58ae203
measure [clinicaltrials_vocabulary:measure]
The primary endpoint of this s ...... n the trial will be secondary.
time frame [clinicaltrials_vocabulary:time-frame]
description
Follow-up time after primary surgery is 24 months.
identifier
clinicaltrials_resource:088cfec033000d0d544b2cedf58ae203
title
The primary endpoint of this s ...... l will be secondary. 24 months
@en
type
label
The primary endpoint of this s ...... cfec033000d0d544b2cedf58ae203]
@en